Alto Ingredients Inc. (ALTO) β€” RQD Stock Rating Cockpit

$3.65 0.00% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $3.64

Alto Ingredients Inc. (ALTO) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D β€’ SELL / AVOID Cap $283.1M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on ALTO Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is ALTO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-02, Alto Ingredients Inc. (NASDAQ: ALTO) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $3.65 (0.00% 1D, market cap $283.1M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 10/20. Across 270 tracked Materials issuers, ALTO ranks #144 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does ALTO compare to GEVO and OEC in the Materials sector?
β–Ό

Within the Materials sector (Major Chemicals), ALTO carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 3.8%, and ROIC of 2.0%. By comparison, GEVO (Gevo Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -2.9%, cap $299.2M) and OEC (Orion S.A.) posts a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M). Among the 5-stock peer group, ALTO leads on earnings multiple (N/A) while OEC leads on capital efficiency (2.2% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for ALTO?
β–Ό

Per ALTO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000778164), Alto Ingredients Inc. generated $917.9M in revenue (-4.9% YoY), $13.3K in net income, and $8.6M in free cash flow against $388.8M in total assets and $63.0M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $3.64 (-0.19%)🧬 Cannibal Buyback (-0.68% YoY Shares)βš™οΈ Cash Engine: 10/20 (D) β€’ 0.9% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (46/100 Β· D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERSELL / AVOID β€’ D
025507510046
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D Β· Rk D
Cash (10)Whales (7)SEC (10)Macro (9)CEO (10)
Each axis scored 0–20
12M PRICE TARGET CONE-5.5% Base Target
$6 Bull$3 Base$3 Bear
πŸ“¬ FREE ALTO RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for ALTO)Realized 20D OHLCV Swing Band: Β±7.1%
Deterministic 5-Pillar Attribution (46/100 Composite)
πŸ” WHY ALTO SCORES 46/100 (D) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Cash Engine Quality+10/20 pts (22% of score)

SEC XBRL FY 2025 (10-K): 0.9% FCF Margin ($8.6M FCF) & 3.8% Gross Margin

β–² #2 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (22% of score)

Altman Z-Score 0.98 (DISTRESS RISK (<1.8)) β€’ Piotroski F-Score 7/9

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning7/20 pts (-13 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-13 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
54
Grade C-$3.66-4.6% Next Q
Q2 (-2Q)
51
Grade C-$3.49+4.9% Next Q
Q3 (-1Q)
49
Grade D$3.66-0.3% Next Q
Current
46
Grade D$3.65-6.1% Hist 90D Ξ±
Trajectory: C- (54) β†’ D (46)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a ALTO Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While ALTO currently carries a cautious 46/100 (D) rating due to Whale & Options Positioning (7/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Materials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.82) and Max Pain ($3.83) forces dealer call-delta covering toward $6.42.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.68% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $ALTOβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œALTO Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
45.730 Oversold Β· 70 Hot
ALTMAN-Z SHIELDDISTRESS RISK (<1.8)
0.98>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
7 / 99-Pt Accounting
52-WEEK LASER RANGE52% OF RANGE
L: $1$3.65H: $6
1. Money & Cash Health● WEAK
Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: DRQD 10 / 20
2. Big Money & Insiders● TRIMMING
Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 17 / 40
3. Hidden Risks & Market Weather● WARNING
SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 19 / 40
MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on ALTO

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
BEARISH (50)

2.0% ROIC with 3.8% gross margin and 3.05% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
BEARISH (50)

Altman-Z 0.98 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BEARISH (43)

17/40 institutional & smart-money positioning score with 9/20 macro alignment.

Bull Case: Why Buyers Like ALTO
  • βœ“Established market leader in Materials with deep daily trading liquidity.
Bear Case: What Could Go Wrong
  • !Company executives have done more routine share selling than personal cash buying lately.
  • !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ALTO)

  • βœ“Walkthrough of ALTO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
ALTO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -33.27%⚑ TESTING RESISTANCE
2026-11-02O $3.66H $3.66L $3.65C $3.65VOL 668.9K
RES: $3.69SUP: $3.25SMA50: $3.82SMA200: $4.29
$6.37$5.30$4.23$3.17$2.10RES $3.69SUP $3.25$3.652026-05-042026-06-172026-08-042026-09-172026-11-02
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

ALTO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
27.5%/yr Implied 5Y Growth

vs. -4.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on ALTO today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for ALTO. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ALTO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ALTO)

1. Head-to-Head Materials Peer Comparison (ALTO vs. GEVO, OEC, FF, ASPI)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Alto Ingredients Inc. (ALTO) ranks #144 by composite RQD confidence (46/100, grade D) and #203 by equity capitalization ($283.1M). Within this direct 5-issuer industry benchmark cohort, ALTO leads on earnings valuation at N/A trailing P/E, while OEC leads on capital efficiency and profitability with 2.2% ROIC and 19.9% gross margin. ALTO currently leads its immediate peer cohort in composite quantitative strength at 46/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
ALTO ACTIVE
Alto Ingredients Inc.
D 46/100 β€” 3.8% 2.0% 0.00% $283.1M Benchmark Subject
GEVO
Gevo Inc.
E 24/100 β€” β€” -2.9% +3.31% $299.2M /gevo-vs-alto β†’
OEC
Orion S.A.
D- 39/100 β€” 19.9% 2.2% +1.08% $313.1M /oec-vs-alto β†’
FF
FutureFuel Corp.
D- 39/100 β€” -30.0% -35.0% -0.35% $249.6M /ff-vs-alto β†’
ASPI
ASP Isotopes Inc.
E 21/100 β€” 14.3% -35.0% -5.16% $326.5M /aspi-vs-alto β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0000778164

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alto Ingredients Inc. (ALTO) reported GAAP revenue of $917.9M (-4.9% vs. FY2024 revenue of $965.3M , and -24.9% cumulative change since FY2023) , GAAP net income of $13.3K, operating cash flow of $13.2M, and free cash flow of $8.6M (+159.3% YoY). On the balance sheet, ALTO closed FY2025 with $388.8M in total assets against $63.0M in total debt (Altman Z-Score: 0.98, Piotroski F-Score: 7/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $917.9M $13.3K $13.2M $8.6M $388.8M $63.0M
FY2024 (FY) 2024-12-31 $965.3M -$59.0K -$3.5M -$14.6M $401.4M $92.9M
FY2023 (FY) 2023-12-31 $1.22B -$29.3M $22.0M $22.0M β€” β€”

3. ALTO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is ALTO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-02, Alto Ingredients Inc. (NASDAQ: ALTO) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $3.65 (0.00% 1D, market cap $283.1M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 10/20. Across 270 tracked Materials issuers, ALTO ranks #144 in composite RQD confidence.

How does ALTO compare to GEVO and OEC in the Materials sector?

Within the Materials sector (Major Chemicals), ALTO carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 3.8%, and ROIC of 2.0%. By comparison, GEVO (Gevo Inc.) holds a E grade (24/100 RQD, P/E N/A, ROIC -2.9%, cap $299.2M) and OEC (Orion S.A.) posts a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M). Among the 5-stock peer group, ALTO leads on earnings multiple (N/A) while OEC leads on capital efficiency (2.2% ROIC).

What are the biggest fundamental strengths and SEC risk factors for ALTO?

Per ALTO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000778164), Alto Ingredients Inc. generated $917.9M in revenue (-4.9% YoY), $13.3K in net income, and $8.6M in free cash flow against $388.8M in total assets and $63.0M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is ALTO trading relative to its 50-day, 200-day, and 52-week technical levels?

ALTO last traded at $3.65 (0.00% on volume of 625,915 shares), positioning the stock -4.45% below its 50-day simple moving average ($3.82) and -14.92% below its 200-day simple moving average ($4.29). Across its 52-week range of $0.99 to $6.11, ALTO sits at the 52.0% percentile with a 14-day RSI of 45.7 (NEUTRAL RANGE) and an implied next-earnings move of Β±7.1% ($3.39 to $3.91).

ALTO Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS β€’ SEC EDGAR Γ— CBOE Γ— FRED

Should I buy, hold, or sell ALTO stock right now?

Alto Ingredients Inc. (ALTO) currently earns a Roarable Rating of D (Sell β€” SELL) with 46/100 RQD Confidence. Stretched risk/reward at current multiples (2% return on capital) under elevated 10-year interest-rate pressure.

What is ALTO's 12-month price target and RQD AI Jury consensus?

ALTO's 12-month base price target is $3.45 (range $2.69 to $6.42), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

ROARABLE RATING BRIEF β€’ RQD 46/100 (D) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

ALTO β€” Alto Ingredients Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:39:14Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD rating is 46, a letter grade of D, with the verdict "Roarable Sell β€” Underperform / Distribution Warning" (per the Roarable RQD rating). Across the five pillars, the scores are:

  • Fundamental Cash Engine: 10 / 20 β€” ROIC of 2% and FCF yield of 3.05% (per the Roarable RQD rating and market data). Returns on invested capital are thin relative to what a prospective investor would typically require from a durable operating business.
  • Whale 13F Flow: 7 / 20 β€” Institutional accumulation and options positioning are scored weakly (per the Roarable RQD rating). The source data contains no holder detail to explain the score (per the holders section: Not available in source data).
  • Insider Conviction: 10 / 20 β€” SEC Form 4 and Congressional PTR cluster flow are scored at 10 (per the Roarable RQD rating). No underlying transaction records are provided in the source data.
  • Macro Regime Fit: 9 / 20 β€” Beta of 1.0 and sector sensitivity are scored at 9 (per the Roarable RQD rating and market data). The stock's behavior is therefore described as tracking the market at unit beta, without a demonstrated regime advantage.
  • Forensic Balance Sheet: 10 / 20 β€” Altman Z of 0.98, Piotroski F of 7/9, and Debt/Equity of 0.26 are cited (per the Roarable RQD rating). An Altman Z of 0.98 sits in a range commonly associated with financial distress, while the Piotroski F of 7/9 and low Debt/Equity point in the other direction, so the forensic picture is mixed.

Taken together, the pillar scores imply that no single area is strong enough to offset weakness elsewhere. For a prospective investor evaluating the stock today, the rating frames the setup as a valuation and quality question: the cash-generation and return metrics are modest, the distribution signal is negative, and the balance-sheet picture is mixed. The rating is a model output and does not constitute personalized financial advice.

Business

Alto Ingredients Inc. is a NASDAQ-listed issuer in the Materials sector and Major Chemicals industry (per the company profile). The source data does not describe its specific products, customers, or revenue model (per the profile: Not available in source data for product and customer detail). The company's revenue of $917.9M in FY 2025 is reported in the financials section, indicating a substantial operating scale relative to its market capitalization of $283.1M.

Financial Trend

PeriodRevenueOperating IncomeNet IncomeEPSFCFCashDebt
FY 2025$917.9M$7.4M$0.0MN/A$8.6M$23.4M$63.0M
FY 2024$965.3M$-51.7M$-0.1MN/A$-14.6M$35.5M$92.9M
FY 2023$1222.9M$-23.8M$-29.3MN/A$22.0MN/AN/A

Per the SEC financials, revenue declined from $1222.9M in FY 2023 to $917.9M in FY 2025, and operating income moved from negative in FY 2023 and FY 2024 to $7.4M in FY 2025. Gross margin is 3.8%, operating margin 0.8%, and net margin 0% (per market data). ROIC is 2% (per market data). The Altman Z-Score of 0.98 and Piotroski F-Score of 7/9 are cited in the Roarable RQD rating, alongside a Debt/Equity of 0.26. Debt declined from $92.9M to $63.0M between FY 2024 and FY 2025, and cash declined from $35.5M to $23.4M over the same period.

Recent Catalysts & News Wire Analysis

  • Scheduled catalyst: Alto Ingredients is slated to release Q3 2026 financial results on November 4, 2026 (per the news wire, flagged YELLOW).
  • Coverage flow: Multiple articles from Simply Wall St, TradingView, MarketBeat, and Yahoo Finance are listed, all flagged YELLOW under the "MARKET WIRE" impact label (per the news wire). The summaries are generic market-coverage descriptions and contain no quantified new information.
  • Price action referenced: One headline references shares climbing 0.6% (per the news wire); the market data shows the current change at -0.27% (per market data).
  • Risk watch items: The news wire contains no specific risk events beyond the scheduled earnings release.
  • Proprietary signals: None are present in the Butterfly Supply-Chain Graph (per the Butterfly Supply-Chain Graph).

Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples

Per the Butterfly Supply-Chain Graph, the supply chain is recorded as "NONE," with no butterfly links and no proprietary signals. The source data therefore does not identify upstream suppliers, downstream customers, or sector correlations. A prospective investor should note that the graph's sector and industry classification (Materials / Major Chemicals) is the only mapped context, and that second-order bottlenecks cannot be assessed from the provided data. The Q3 2026 earnings release on November 4, 2026 is the nearest identified event to monitor for operating-level signals.

Open Questions

  • What are the company's specific products, customers, and revenue drivers, given that the source data describes only the sector and industry?
  • What explains the drop in revenue from $1222.9M in FY 2023 to $917.9M in FY 2025, and is the operating-income turn to $7.4M in FY 2025 sustainable?
  • What are the EPS and P/E (TTM) values, which are reported as not available in source data despite a reported net income figure?
  • What drove the Altman Z-Score of 0.98 and how does it reconcile with a Piotroski F-Score of 7/9 and Debt/Equity of 0.26?
  • What do the Q3 2026 results on November 4, 2026 show relative to the FY 2025 baseline, and who holds the shares (holders data is absent)?

ALTO Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Alto Ingredients Inc. (ALTO) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to ALTO Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

ALTO Bull vs. Bear Conversation Board β€” What's Your Call at $3.65?

πŸ‚ 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON ALTO 🐻 50% BEARISH CONVICTION
1. Pick Your Side on ALTO:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
RO RoarDesk_Moderator Roarable Research Desk βš–οΈ DEBATE HOST 🎯 Target: $3.94 (+7.9%)
πŸ“Œ Pinned Debate

πŸ”₯ Official Bull vs. Bear Debate: Is ALTO (D β€’ RQD 46/100) a Buy at $3.65?

Welcome to the ALTO (Alto Ingredients Inc.) Roar Pit. Current RQD Composite is 46/100 (Roarable Sell β€” Underperform / Distribution Warning) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (πŸ‚ Bull or 🐻 Bear) and drop your price target below.

SH ShortSeller_Dan Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $3.03 (-17.0%)
Spot @ $3.65

Pump the brakes on ALTO β€” check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on ALTO, but look at what you are paying: current EV/EBITDA multiples with 3.8% gross margins. Unless Alto Ingredients Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

TA TapeReader_Pro Verified K Arena Trader πŸ‚ BULLISH 🎯 Target: $4.20 (+15.1%)
Spot @ $3.65

ALTO cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on ALTO, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $3.65 (52-wk range $0.99 - $6.11), any beat on forward guidance forces shorts and underweight funds to chase.

LIVE TAPE SPY $755.72 -0.38% QQQ $690.49 -1.44% DIA $517.13 -0.37% IWM $279.33 +0.96% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.36 -0.94% GLD $355.78 -1.34%